NAYA Biologics focuses on the design & development of best-in-class multifunctional antibodies to address unmet medical needs for the treatment of cancer and autoimmune diseases. Our capabilities include a proprietary multifunctional antibody platform, enhanced by integrated partnerships with MabSilico for AI/Machine Learning, LynxBio for the application of multiomics to translational drug profiling, and STC Biologics for process development and GMP manufacturing.
 
We aim to achieve competitive target product profiles of new therapeutic candidates to support further development by a clinical-stage NAYA spoke or out-licensing to a strategic partner.